Advertisement

Index by author

July 01, 1987; Volume 32,Issue 1

A

  1. Ahlijanian, M K

    1. Calmodulin may play a pivotal role in neurotransmitter-mediated inhibition and stimulation of rat cerebellar adenylate cyclase.
      M K Ahlijanian and D M Cooper
      Molecular Pharmacology July 1987, 32 (1) 127-132;

  2. Aiyar, N

    1. Solubilization and reconstitution of vasopressin V1 receptors of rat liver.
      N Aiyar, P Nambi, F Stassen and S T Crooke
      Molecular Pharmacology July 1987, 32 (1) 34-36;

  3. Akera, T

    1. Ligand effects on membrane lipids associated with sodium, potassium-activated adenosine triphosphatase: comparative spin probe studies with rat brain and heart enzyme preparations.
      R T Coughlin, T Akera, E J McGroarty and C Steinbach
      Molecular Pharmacology July 1987, 32 (1) 147-153;
    2. Relative abundance of two molecular forms of Na+,K+-ATPase in the ferret heart: developmental changes and associated alterations of digitalis sensitivity.
      Y C Ng and T Akera
      Molecular Pharmacology August 1987, 32 (1) 201-205;

B

  1. Balzarini, J

    1. The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.
      J Balzarini, G J Kang, M Dalal, P Herdewijn, E De Clercq, S Broder and D G Johns
      Molecular Pharmacology July 1987, 32 (1) 162-167;

  2. Bao, Z P

    1. Stereoselective formations of K-region and non-K-region epoxides in the metabolism of chrysene by rat liver microsomal cytochrome P-450 isozymes.
      S K Yang and Z P Bao
      Molecular Pharmacology July 1987, 32 (1) 73-80;

  3. Belinsky, S A

    1. Effect of beta-naphthoflavone on mitochondrial supply of reducing equivalents for monooxygenation in periportal and pericentral regions of the liver lobule.
      S A Belinsky, F W Kari, F C Kauffman and R G Thurman
      Molecular Pharmacology August 1987, 32 (1) 315-320;

  4. Bentrude, W G

    1. Potent activity of 5-fluoro-2'-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase.
      E De Clercq, J Bères and W G Bentrude
      Molecular Pharmacology August 1987, 32 (1) 286-292;

  5. Benz, C

    1. Effects of cis- and trans-tamoxifen isomers on RNA incorporation of human breast cancer cells.
      C Benz and G F Santos
      Molecular Pharmacology July 1987, 32 (1) 13-16;

  6. Bères, J

    1. Potent activity of 5-fluoro-2'-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase.
      E De Clercq, J Bères and W G Bentrude
      Molecular Pharmacology August 1987, 32 (1) 286-292;

  7. Berger, K D

    1. The relationship between alpha 1-adrenergic receptor occupancy and response in BC3H-1 muscle cells.
      R D Brown, K D Berger and P Taylor
      Molecular Pharmacology July 1987, 32 (1) 43-52;

  8. Birkett, D J

    1. Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liver.
      M E McManus, P D Hall, I Stupans, J Brennan, W Burgess, R Robson and D J Birkett
      Molecular Pharmacology August 1987, 32 (1) 189-194;

  9. Blank, J A

    1. alpha-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression.
      J A Blank, A N Tucker, J Sweatlock, T A Gasiewicz and M I Luster
      Molecular Pharmacology July 1987, 32 (1) 169-172;

  10. Bock, K W

    1. Regioselectivity of rat liver microsomal UDP-glucuronosyltransferase activities toward phenols of benzo(a)pyrene and dibenz(a,h)anthracene.
      W Lilienblum, K L Platt, G Schirmer, F Oesch and K W Bock
      Molecular Pharmacology July 1987, 32 (1) 173-177;

  11. Bornheim, L M

    1. Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implications.
      L M Bornheim, M C Underwood, P Caldera, A E Rettie, W F Trager, S A Wrighton and M A Correia
      Molecular Pharmacology August 1987, 32 (1) 299-308;

  12. Braswell, L M

    1. Barbiturates bind to an allosteric regulatory site on nicotinic acetylcholine receptor-rich membranes.
      B A Dodson, L M Braswell and K W Miller
      Molecular Pharmacology July 1987, 32 (1) 119-126;

  13. Brennan, J

    1. Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liver.
      M E McManus, P D Hall, I Stupans, J Brennan, W Burgess, R Robson and D J Birkett
      Molecular Pharmacology August 1987, 32 (1) 189-194;

  14. Broder, S

    1. The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.
      J Balzarini, G J Kang, M Dalal, P Herdewijn, E De Clercq, S Broder and D G Johns
      Molecular Pharmacology July 1987, 32 (1) 162-167;

  15. Brown, R D

    1. The relationship between alpha 1-adrenergic receptor occupancy and response in BC3H-1 muscle cells.
      R D Brown, K D Berger and P Taylor
      Molecular Pharmacology July 1987, 32 (1) 43-52;

  16. Burgess, W

    1. Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liver.
      M E McManus, P D Hall, I Stupans, J Brennan, W Burgess, R Robson and D J Birkett
      Molecular Pharmacology August 1987, 32 (1) 189-194;

C

  1. Caldera, P

    1. Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implications.
      L M Bornheim, M C Underwood, P Caldera, A E Rettie, W F Trager, S A Wrighton and M A Correia
      Molecular Pharmacology August 1987, 32 (1) 299-308;

  2. Candelore, M R

    1. Beta-adrenergic receptor subtype is an intrinsic property of the receptor gene product.
      C D Strader, M R Candelore, E Rands and R A Dixon
      Molecular Pharmacology August 1987, 32 (1) 179-183;

  3. Christophe, J

    1. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
      M Gillard, M Waelbroeck and J Christophe
      Molecular Pharmacology July 1987, 32 (1) 100-108;
    2. Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
      M Waelbroeck, M Gillard, P Robberecht and J Christophe
      Molecular Pharmacology July 1987, 32 (1) 91-99;

  4. Colucci, W S

    1. Phorbol ester-stimulated bidirectional transmembrane calcium flux in A7r5 vascular smooth muscle cells.
      G Sperti and W S Colucci
      Molecular Pharmacology July 1987, 32 (1) 37-42;

  5. Convents, A

    1. Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors.
      A Convents, J P De Backer, D Convents and G Vauquelin
      Molecular Pharmacology July 1987, 32 (1) 65-72;

  6. Convents, D

    1. Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors.
      A Convents, J P De Backer, D Convents and G Vauquelin
      Molecular Pharmacology July 1987, 32 (1) 65-72;

  7. Cooper, D M

    1. Calmodulin may play a pivotal role in neurotransmitter-mediated inhibition and stimulation of rat cerebellar adenylate cyclase.
      M K Ahlijanian and D M Cooper
      Molecular Pharmacology July 1987, 32 (1) 127-132;
    2. Calmodulin stimulation of the rat cerebral cortical adenylate cyclase is required for the detection of guanine nucleotide- or hormone-mediated inhibition.
      E Perez-Reyes and D M Cooper
      Molecular Pharmacology August 1987, 32 (1) 212-216;

  8. Correia, M A

    1. Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implications.
      L M Bornheim, M C Underwood, P Caldera, A E Rettie, W F Trager, S A Wrighton and M A Correia
      Molecular Pharmacology August 1987, 32 (1) 299-308;

  9. Coughlin, R T

    1. Ligand effects on membrane lipids associated with sodium, potassium-activated adenosine triphosphatase: comparative spin probe studies with rat brain and heart enzyme preparations.
      R T Coughlin, T Akera, E J McGroarty and C Steinbach
      Molecular Pharmacology July 1987, 32 (1) 147-153;

  10. Crooke, S T

    1. Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.
      S R Per, M R Mattern, C K Mirabelli, F H Drake, R K Johnson and S T Crooke
      Molecular Pharmacology July 1987, 32 (1) 17-25;
    2. Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be related.
      R G Shorr, M D Minnich, A Varrichio, M W Strohsacker, L Gotlib, L I Kruse, W E DeWolf and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 195-200;
    3. SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
      S Mong, H L Wu, J Miller, R F Hall, J G Gleason and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 223-229;
    4. Solubilization and reconstitution of vasopressin V1 receptors of rat liver.
      N Aiyar, P Nambi, F Stassen and S T Crooke
      Molecular Pharmacology July 1987, 32 (1) 34-36;

D

  1. Dalal, M

    1. The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.
      J Balzarini, G J Kang, M Dalal, P Herdewijn, E De Clercq, S Broder and D G Johns
      Molecular Pharmacology July 1987, 32 (1) 162-167;

  2. De Backer, J P

    1. Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors.
      A Convents, J P De Backer, D Convents and G Vauquelin
      Molecular Pharmacology July 1987, 32 (1) 65-72;

  3. De Clercq, E

    1. The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.
      J Balzarini, G J Kang, M Dalal, P Herdewijn, E De Clercq, S Broder and D G Johns
      Molecular Pharmacology July 1987, 32 (1) 162-167;
    2. Potent activity of 5-fluoro-2'-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase.
      E De Clercq, J Bères and W G Bentrude
      Molecular Pharmacology August 1987, 32 (1) 286-292;

  4. Dehmel, V C

    1. Interactions between adenosine and alpha 1-adrenergic agonists in regulation of respiration in hamster brown adipocytes.
      R J Schimmel, M E Elliott and V C Dehmel
      Molecular Pharmacology July 1987, 32 (1) 26-33;

  5. De Souza, N J

    1. Stimulation of adenylate cyclase by water-soluble analogues of forskolin.
      A Laurenza, Y Khandelwal, N J De Souza, R H Rupp, H Metzger and K B Seamon
      Molecular Pharmacology July 1987, 32 (1) 133-139;

  6. DeWolf, W E

    1. Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be related.
      R G Shorr, M D Minnich, A Varrichio, M W Strohsacker, L Gotlib, L I Kruse, W E DeWolf and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 195-200;

  7. Diamond, J

    1. Evidence that cGMP is the mediator of endothelium-dependent inhibition of contractile responses of rat arteries to alpha-adrenoceptor stimulation.
      K M MacLeod, D D Ng, K H Harris and J Diamond
      Molecular Pharmacology July 1987, 32 (1) 59-64;

  8. Dixon, R A

    1. Beta-adrenergic receptor subtype is an intrinsic property of the receptor gene product.
      C D Strader, M R Candelore, E Rands and R A Dixon
      Molecular Pharmacology August 1987, 32 (1) 179-183;

  9. Dodson, B A

    1. Barbiturates bind to an allosteric regulatory site on nicotinic acetylcholine receptor-rich membranes.
      B A Dodson, L M Braswell and K W Miller
      Molecular Pharmacology July 1987, 32 (1) 119-126;

  10. Drake, F H

    1. Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.
      S R Per, M R Mattern, C K Mirabelli, F H Drake, R K Johnson and S T Crooke
      Molecular Pharmacology July 1987, 32 (1) 17-25;

E

  1. Elliott, M E

    1. Interactions between adenosine and alpha 1-adrenergic agonists in regulation of respiration in hamster brown adipocytes.
      R J Schimmel, M E Elliott and V C Dehmel
      Molecular Pharmacology July 1987, 32 (1) 26-33;

F

  1. Fisher, S K

    1. Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas.
      S K Fisher and R M Snider
      Molecular Pharmacology July 1987, 32 (1) 81-90;

G

  1. Galper, J B

    1. Muscarinic cholinergic receptors in the embryonic chick heart: interaction of agonist, receptor, and guanine nucleotides studied by an improved assay for direct binding of the muscarinic agonist [3H]cismethyldioxolane.
      J B Galper, L S Haigh, A C Hart, D S O'Hara and D J Livingston
      Molecular Pharmacology August 1987, 32 (1) 230-240;

  2. Gasiewicz, T A

    1. alpha-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression.
      J A Blank, A N Tucker, J Sweatlock, T A Gasiewicz and M I Luster
      Molecular Pharmacology July 1987, 32 (1) 169-172;

  3. Gillard, M

    1. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
      M Gillard, M Waelbroeck and J Christophe
      Molecular Pharmacology July 1987, 32 (1) 100-108;
    2. Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
      M Waelbroeck, M Gillard, P Robberecht and J Christophe
      Molecular Pharmacology July 1987, 32 (1) 91-99;

  4. Gleason, J G

    1. SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
      S Mong, H L Wu, J Miller, R F Hall, J G Gleason and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 223-229;

  5. Gotlib, L

    1. Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be related.
      R G Shorr, M D Minnich, A Varrichio, M W Strohsacker, L Gotlib, L I Kruse, W E DeWolf and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 195-200;

H

  1. Hagiwara, M

    1. Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
      M Hagiwara, M Inagaki, M Watanabe, M Ito, K Onoda, T Tanaka and H Hidaka
      Molecular Pharmacology July 1987, 32 (1) 7-12;

  2. Haigh, L S

    1. Muscarinic cholinergic receptors in the embryonic chick heart: interaction of agonist, receptor, and guanine nucleotides studied by an improved assay for direct binding of the muscarinic agonist [3H]cismethyldioxolane.
      J B Galper, L S Haigh, A C Hart, D S O'Hara and D J Livingston
      Molecular Pharmacology August 1987, 32 (1) 230-240;

  3. Hall, P D

    1. Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liver.
      M E McManus, P D Hall, I Stupans, J Brennan, W Burgess, R Robson and D J Birkett
      Molecular Pharmacology August 1987, 32 (1) 189-194;

  4. Hall, R F

    1. SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
      S Mong, H L Wu, J Miller, R F Hall, J G Gleason and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 223-229;

  5. Hantelle, P

    1. Co-induction of cytochrome P-450 isozymes in rat liver by 2,4,5,2',4',5'-hexachlorobiphenyl or 3-methoxy-4-aminoazobenzene.
      M Kelley, P Hantelle, S Safe, W Levin and P E Thomas
      Molecular Pharmacology August 1987, 32 (1) 206-211;

  6. Harbon, S

    1. Heterologous regulations of cAMP responses in pregnant rat myometrium. Evolution from a stimulatory to an inhibitory prostaglandin E2 and prostacyclin effect.
      Z Tanfin and S Harbon
      Molecular Pharmacology August 1987, 32 (1) 249-257;

  7. Harris, K H

    1. Evidence that cGMP is the mediator of endothelium-dependent inhibition of contractile responses of rat arteries to alpha-adrenoceptor stimulation.
      K M MacLeod, D D Ng, K H Harris and J Diamond
      Molecular Pharmacology July 1987, 32 (1) 59-64;

  8. Hart, A C

    1. Muscarinic cholinergic receptors in the embryonic chick heart: interaction of agonist, receptor, and guanine nucleotides studied by an improved assay for direct binding of the muscarinic agonist [3H]cismethyldioxolane.
      J B Galper, L S Haigh, A C Hart, D S O'Hara and D J Livingston
      Molecular Pharmacology August 1987, 32 (1) 230-240;

  9. Herdewijn, P

    1. The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.
      J Balzarini, G J Kang, M Dalal, P Herdewijn, E De Clercq, S Broder and D G Johns
      Molecular Pharmacology July 1987, 32 (1) 162-167;

  10. Hidaka, H

    1. Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
      M Hagiwara, M Inagaki, M Watanabe, M Ito, K Onoda, T Tanaka and H Hidaka
      Molecular Pharmacology July 1987, 32 (1) 7-12;

  11. Hoffman, P L

    1. Effect of ethanol on mouse cerebral cortical beta-adrenergic receptors.
      P Valverius, P L Hoffman and B Tabakoff
      Molecular Pharmacology August 1987, 32 (1) 217-222;

  12. Howard, M J

    1. Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
      R M McKernan, M J Howard, H J Motulsky and P A Insel
      Molecular Pharmacology August 1987, 32 (1) 258-265;
    2. Interactions of amiloride with alpha- and beta-adrenergic receptors: amiloride reveals an allosteric site on alpha 2-adrenergic receptors.
      M J Howard, R J Hughes, H J Motulsky, M D Mullen and P A Insel
      Molecular Pharmacology July 1987, 32 (1) 53-58;

  13. Hughes, R J

    1. Interactions of amiloride with alpha- and beta-adrenergic receptors: amiloride reveals an allosteric site on alpha 2-adrenergic receptors.
      M J Howard, R J Hughes, H J Motulsky, M D Mullen and P A Insel
      Molecular Pharmacology July 1987, 32 (1) 53-58;

I

  1. Inagaki, M

    1. Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
      M Hagiwara, M Inagaki, M Watanabe, M Ito, K Onoda, T Tanaka and H Hidaka
      Molecular Pharmacology July 1987, 32 (1) 7-12;

  2. Insel, P A

    1. Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
      R M McKernan, M J Howard, H J Motulsky and P A Insel
      Molecular Pharmacology August 1987, 32 (1) 258-265;
    2. Interactions of amiloride with alpha- and beta-adrenergic receptors: amiloride reveals an allosteric site on alpha 2-adrenergic receptors.
      M J Howard, R J Hughes, H J Motulsky, M D Mullen and P A Insel
      Molecular Pharmacology July 1987, 32 (1) 53-58;

  3. Ito, M

    1. Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
      M Hagiwara, M Inagaki, M Watanabe, M Ito, K Onoda, T Tanaka and H Hidaka
      Molecular Pharmacology July 1987, 32 (1) 7-12;

J

  1. Jacobson, K A

    1. A new high affinity, iodinated adenosine receptor antagonist as a radioligand/photoaffinity crosslinking probe.
      G L Stiles and K A Jacobson
      Molecular Pharmacology August 1987, 32 (1) 184-188;

  2. Johns, D G

    1. The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.
      J Balzarini, G J Kang, M Dalal, P Herdewijn, E De Clercq, S Broder and D G Johns
      Molecular Pharmacology July 1987, 32 (1) 162-167;

  3. Johnson, R K

    1. Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.
      S R Per, M R Mattern, C K Mirabelli, F H Drake, R K Johnson and S T Crooke
      Molecular Pharmacology July 1987, 32 (1) 17-25;

K

  1. Kamp, T J

    1. Voltage-dependent nitrendipine binding to cardiac sarcolemmal vesicles.
      T J Kamp and R J Miller
      Molecular Pharmacology August 1987, 32 (1) 278-285;

  2. Kang, G J

    1. The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.
      J Balzarini, G J Kang, M Dalal, P Herdewijn, E De Clercq, S Broder and D G Johns
      Molecular Pharmacology July 1987, 32 (1) 162-167;

  3. Kari, F W

    1. Effect of beta-naphthoflavone on mitochondrial supply of reducing equivalents for monooxygenation in periportal and pericentral regions of the liver lobule.
      S A Belinsky, F W Kari, F C Kauffman and R G Thurman
      Molecular Pharmacology August 1987, 32 (1) 315-320;

  4. Katoh, A

    1. Selective calmodulin inhibition toward myosin light chain kinase by a new cerebral circulation improver, Ro 22-4839.
      T Nakajima and A Katoh
      Molecular Pharmacology July 1987, 32 (1) 140-146;

  5. Kauffman, F C

    1. Effect of beta-naphthoflavone on mitochondrial supply of reducing equivalents for monooxygenation in periportal and pericentral regions of the liver lobule.
      S A Belinsky, F W Kari, F C Kauffman and R G Thurman
      Molecular Pharmacology August 1987, 32 (1) 315-320;

  6. Kazmi, S M

    1. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.
      S M Kazmi and R K Mishra
      Molecular Pharmacology July 1987, 32 (1) 109-118;

  7. Kelley, M

    1. Co-induction of cytochrome P-450 isozymes in rat liver by 2,4,5,2',4',5'-hexachlorobiphenyl or 3-methoxy-4-aminoazobenzene.
      M Kelley, P Hantelle, S Safe, W Levin and P E Thomas
      Molecular Pharmacology August 1987, 32 (1) 206-211;

  8. Khandelwal, Y

    1. Stimulation of adenylate cyclase by water-soluble analogues of forskolin.
      A Laurenza, Y Khandelwal, N J De Souza, R H Rupp, H Metzger and K B Seamon
      Molecular Pharmacology July 1987, 32 (1) 133-139;

  9. Kruse, L I

    1. Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be related.
      R G Shorr, M D Minnich, A Varrichio, M W Strohsacker, L Gotlib, L I Kruse, W E DeWolf and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 195-200;

L

  1. Laurenza, A

    1. Stimulation of adenylate cyclase by water-soluble analogues of forskolin.
      A Laurenza, Y Khandelwal, N J De Souza, R H Rupp, H Metzger and K B Seamon
      Molecular Pharmacology July 1987, 32 (1) 133-139;

  2. Laychock, S G

    1. Alpha 2-adrenoceptor stimulation affects total glucose utilization in isolated islets of Langerhans.
      S G Laychock
      Molecular Pharmacology August 1987, 32 (1) 241-248;

  3. Levin, W

    1. Co-induction of cytochrome P-450 isozymes in rat liver by 2,4,5,2',4',5'-hexachlorobiphenyl or 3-methoxy-4-aminoazobenzene.
      M Kelley, P Hantelle, S Safe, W Levin and P E Thomas
      Molecular Pharmacology August 1987, 32 (1) 206-211;

  4. Lilienblum, W

    1. Regioselectivity of rat liver microsomal UDP-glucuronosyltransferase activities toward phenols of benzo(a)pyrene and dibenz(a,h)anthracene.
      W Lilienblum, K L Platt, G Schirmer, F Oesch and K W Bock
      Molecular Pharmacology July 1987, 32 (1) 173-177;

  5. Livingston, D J

    1. Muscarinic cholinergic receptors in the embryonic chick heart: interaction of agonist, receptor, and guanine nucleotides studied by an improved assay for direct binding of the muscarinic agonist [3H]cismethyldioxolane.
      J B Galper, L S Haigh, A C Hart, D S O'Hara and D J Livingston
      Molecular Pharmacology August 1987, 32 (1) 230-240;

  6. Lönn, S

    1. Treatment with dilute alkali-nuclease S1 permits the analysis of DNA damage: cells treated with platinum analogues.
      U Lönn and S Lönn
      Molecular Pharmacology July 1987, 32 (1) 154-161;

  7. Lönn, U

    1. Treatment with dilute alkali-nuclease S1 permits the analysis of DNA damage: cells treated with platinum analogues.
      U Lönn and S Lönn
      Molecular Pharmacology July 1987, 32 (1) 154-161;

  8. Luster, M I

    1. alpha-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression.
      J A Blank, A N Tucker, J Sweatlock, T A Gasiewicz and M I Luster
      Molecular Pharmacology July 1987, 32 (1) 169-172;

M

  1. MacLeod, K M

    1. Evidence that cGMP is the mediator of endothelium-dependent inhibition of contractile responses of rat arteries to alpha-adrenoceptor stimulation.
      K M MacLeod, D D Ng, K H Harris and J Diamond
      Molecular Pharmacology July 1987, 32 (1) 59-64;

  2. Makar, A B

    1. The role of formate and S-adenosylmethionine in the reversal of nitrous oxide inhibition of formate oxidation in the rat.
      A B Makar and T R Tephly
      Molecular Pharmacology August 1987, 32 (1) 309-314;

  3. Manning, D R

    1. Structural characteristics of the 35- and 36-kDa forms of the beta subunit common to GTP-binding regulatory proteins.
      M J Woolkalis and D R Manning
      Molecular Pharmacology July 1987, 32 (1) 1-6;

  4. Mattern, M R

    1. Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.
      S R Per, M R Mattern, C K Mirabelli, F H Drake, R K Johnson and S T Crooke
      Molecular Pharmacology July 1987, 32 (1) 17-25;

  5. McGroarty, E J

    1. Ligand effects on membrane lipids associated with sodium, potassium-activated adenosine triphosphatase: comparative spin probe studies with rat brain and heart enzyme preparations.
      R T Coughlin, T Akera, E J McGroarty and C Steinbach
      Molecular Pharmacology July 1987, 32 (1) 147-153;

  6. McKernan, R M

    1. Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
      R M McKernan, M J Howard, H J Motulsky and P A Insel
      Molecular Pharmacology August 1987, 32 (1) 258-265;

  7. McManus, M E

    1. Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liver.
      M E McManus, P D Hall, I Stupans, J Brennan, W Burgess, R Robson and D J Birkett
      Molecular Pharmacology August 1987, 32 (1) 189-194;

  8. Metzger, H

    1. Stimulation of adenylate cyclase by water-soluble analogues of forskolin.
      A Laurenza, Y Khandelwal, N J De Souza, R H Rupp, H Metzger and K B Seamon
      Molecular Pharmacology July 1987, 32 (1) 133-139;

  9. Miller, J

    1. SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
      S Mong, H L Wu, J Miller, R F Hall, J G Gleason and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 223-229;

  10. Miller, K W

    1. Barbiturates bind to an allosteric regulatory site on nicotinic acetylcholine receptor-rich membranes.
      B A Dodson, L M Braswell and K W Miller
      Molecular Pharmacology July 1987, 32 (1) 119-126;

  11. Miller, R J

    1. Voltage-dependent nitrendipine binding to cardiac sarcolemmal vesicles.
      T J Kamp and R J Miller
      Molecular Pharmacology August 1987, 32 (1) 278-285;

  12. Minnich, M D

    1. Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be related.
      R G Shorr, M D Minnich, A Varrichio, M W Strohsacker, L Gotlib, L I Kruse, W E DeWolf and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 195-200;

  13. Mirabelli, C K

    1. Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.
      S R Per, M R Mattern, C K Mirabelli, F H Drake, R K Johnson and S T Crooke
      Molecular Pharmacology July 1987, 32 (1) 17-25;

  14. Mishra, R K

    1. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.
      S M Kazmi and R K Mishra
      Molecular Pharmacology July 1987, 32 (1) 109-118;

  15. Mong, S

    1. SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
      S Mong, H L Wu, J Miller, R F Hall, J G Gleason and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 223-229;

  16. Motulsky, H J

    1. Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
      R M McKernan, M J Howard, H J Motulsky and P A Insel
      Molecular Pharmacology August 1987, 32 (1) 258-265;
    2. Interactions of amiloride with alpha- and beta-adrenergic receptors: amiloride reveals an allosteric site on alpha 2-adrenergic receptors.
      M J Howard, R J Hughes, H J Motulsky, M D Mullen and P A Insel
      Molecular Pharmacology July 1987, 32 (1) 53-58;

  17. Mullen, M D

    1. Interactions of amiloride with alpha- and beta-adrenergic receptors: amiloride reveals an allosteric site on alpha 2-adrenergic receptors.
      M J Howard, R J Hughes, H J Motulsky, M D Mullen and P A Insel
      Molecular Pharmacology July 1987, 32 (1) 53-58;

N

  1. Nakajima, T

    1. Selective calmodulin inhibition toward myosin light chain kinase by a new cerebral circulation improver, Ro 22-4839.
      T Nakajima and A Katoh
      Molecular Pharmacology July 1987, 32 (1) 140-146;

  2. Nambi, P

    1. Solubilization and reconstitution of vasopressin V1 receptors of rat liver.
      N Aiyar, P Nambi, F Stassen and S T Crooke
      Molecular Pharmacology July 1987, 32 (1) 34-36;

  3. Ng, D D

    1. Evidence that cGMP is the mediator of endothelium-dependent inhibition of contractile responses of rat arteries to alpha-adrenoceptor stimulation.
      K M MacLeod, D D Ng, K H Harris and J Diamond
      Molecular Pharmacology July 1987, 32 (1) 59-64;

  4. Ng, Y C

    1. Relative abundance of two molecular forms of Na+,K+-ATPase in the ferret heart: developmental changes and associated alterations of digitalis sensitivity.
      Y C Ng and T Akera
      Molecular Pharmacology August 1987, 32 (1) 201-205;

O

  1. O'Hara, D S

    1. Muscarinic cholinergic receptors in the embryonic chick heart: interaction of agonist, receptor, and guanine nucleotides studied by an improved assay for direct binding of the muscarinic agonist [3H]cismethyldioxolane.
      J B Galper, L S Haigh, A C Hart, D S O'Hara and D J Livingston
      Molecular Pharmacology August 1987, 32 (1) 230-240;

  2. Oesch, F

    1. Regioselectivity of rat liver microsomal UDP-glucuronosyltransferase activities toward phenols of benzo(a)pyrene and dibenz(a,h)anthracene.
      W Lilienblum, K L Platt, G Schirmer, F Oesch and K W Bock
      Molecular Pharmacology July 1987, 32 (1) 173-177;

  3. Olsen, R W

    1. gamma-Aminobutyric acid receptor binding in fresh mouse brain membranes at 22 degrees C: ligand-induced changes in affinity.
      J S Yang and R W Olsen
      Molecular Pharmacology August 1987, 32 (1) 266-277;

  4. Onoda, K

    1. Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
      M Hagiwara, M Inagaki, M Watanabe, M Ito, K Onoda, T Tanaka and H Hidaka
      Molecular Pharmacology July 1987, 32 (1) 7-12;

P

  1. Per, S R

    1. Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.
      S R Per, M R Mattern, C K Mirabelli, F H Drake, R K Johnson and S T Crooke
      Molecular Pharmacology July 1987, 32 (1) 17-25;

  2. Perez-Reyes, E

    1. Calmodulin stimulation of the rat cerebral cortical adenylate cyclase is required for the detection of guanine nucleotide- or hormone-mediated inhibition.
      E Perez-Reyes and D M Cooper
      Molecular Pharmacology August 1987, 32 (1) 212-216;

  3. Platt, K L

    1. Regioselectivity of rat liver microsomal UDP-glucuronosyltransferase activities toward phenols of benzo(a)pyrene and dibenz(a,h)anthracene.
      W Lilienblum, K L Platt, G Schirmer, F Oesch and K W Bock
      Molecular Pharmacology July 1987, 32 (1) 173-177;

R

  1. Rands, E

    1. Beta-adrenergic receptor subtype is an intrinsic property of the receptor gene product.
      C D Strader, M R Candelore, E Rands and R A Dixon
      Molecular Pharmacology August 1987, 32 (1) 179-183;

  2. Rettie, A E

    1. Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implications.
      L M Bornheim, M C Underwood, P Caldera, A E Rettie, W F Trager, S A Wrighton and M A Correia
      Molecular Pharmacology August 1987, 32 (1) 299-308;

  3. Robberecht, P

    1. Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
      M Waelbroeck, M Gillard, P Robberecht and J Christophe
      Molecular Pharmacology July 1987, 32 (1) 91-99;

  4. Robson, R

    1. Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liver.
      M E McManus, P D Hall, I Stupans, J Brennan, W Burgess, R Robson and D J Birkett
      Molecular Pharmacology August 1987, 32 (1) 189-194;

  5. Rupp, R H

    1. Stimulation of adenylate cyclase by water-soluble analogues of forskolin.
      A Laurenza, Y Khandelwal, N J De Souza, R H Rupp, H Metzger and K B Seamon
      Molecular Pharmacology July 1987, 32 (1) 133-139;

S

  1. Safe, S

    1. Co-induction of cytochrome P-450 isozymes in rat liver by 2,4,5,2',4',5'-hexachlorobiphenyl or 3-methoxy-4-aminoazobenzene.
      M Kelley, P Hantelle, S Safe, W Levin and P E Thomas
      Molecular Pharmacology August 1987, 32 (1) 206-211;

  2. Santos, G F

    1. Effects of cis- and trans-tamoxifen isomers on RNA incorporation of human breast cancer cells.
      C Benz and G F Santos
      Molecular Pharmacology July 1987, 32 (1) 13-16;

  3. Schaeffer, V H

    1. Mechanism of transport for toxic cysteine conjugates in rat kidney cortex membrane vesicles.
      V H Schaeffer and J L Stevens
      Molecular Pharmacology August 1987, 32 (1) 293-298;

  4. Schimmel, R J

    1. Interactions between adenosine and alpha 1-adrenergic agonists in regulation of respiration in hamster brown adipocytes.
      R J Schimmel, M E Elliott and V C Dehmel
      Molecular Pharmacology July 1987, 32 (1) 26-33;

  5. Schirmer, G

    1. Regioselectivity of rat liver microsomal UDP-glucuronosyltransferase activities toward phenols of benzo(a)pyrene and dibenz(a,h)anthracene.
      W Lilienblum, K L Platt, G Schirmer, F Oesch and K W Bock
      Molecular Pharmacology July 1987, 32 (1) 173-177;

  6. Seamon, K B

    1. Stimulation of adenylate cyclase by water-soluble analogues of forskolin.
      A Laurenza, Y Khandelwal, N J De Souza, R H Rupp, H Metzger and K B Seamon
      Molecular Pharmacology July 1987, 32 (1) 133-139;

  7. Shorr, R G

    1. Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be related.
      R G Shorr, M D Minnich, A Varrichio, M W Strohsacker, L Gotlib, L I Kruse, W E DeWolf and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 195-200;

  8. Snider, R M

    1. Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas.
      S K Fisher and R M Snider
      Molecular Pharmacology July 1987, 32 (1) 81-90;

  9. Sperti, G

    1. Phorbol ester-stimulated bidirectional transmembrane calcium flux in A7r5 vascular smooth muscle cells.
      G Sperti and W S Colucci
      Molecular Pharmacology July 1987, 32 (1) 37-42;

  10. Stassen, F

    1. Solubilization and reconstitution of vasopressin V1 receptors of rat liver.
      N Aiyar, P Nambi, F Stassen and S T Crooke
      Molecular Pharmacology July 1987, 32 (1) 34-36;

  11. Steinbach, C

    1. Ligand effects on membrane lipids associated with sodium, potassium-activated adenosine triphosphatase: comparative spin probe studies with rat brain and heart enzyme preparations.
      R T Coughlin, T Akera, E J McGroarty and C Steinbach
      Molecular Pharmacology July 1987, 32 (1) 147-153;

  12. Stevens, J L

    1. Mechanism of transport for toxic cysteine conjugates in rat kidney cortex membrane vesicles.
      V H Schaeffer and J L Stevens
      Molecular Pharmacology August 1987, 32 (1) 293-298;

  13. Stiles, G L

    1. A new high affinity, iodinated adenosine receptor antagonist as a radioligand/photoaffinity crosslinking probe.
      G L Stiles and K A Jacobson
      Molecular Pharmacology August 1987, 32 (1) 184-188;

  14. Strader, C D

    1. Beta-adrenergic receptor subtype is an intrinsic property of the receptor gene product.
      C D Strader, M R Candelore, E Rands and R A Dixon
      Molecular Pharmacology August 1987, 32 (1) 179-183;

  15. Strohsacker, M W

    1. Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be related.
      R G Shorr, M D Minnich, A Varrichio, M W Strohsacker, L Gotlib, L I Kruse, W E DeWolf and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 195-200;

  16. Stupans, I

    1. Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liver.
      M E McManus, P D Hall, I Stupans, J Brennan, W Burgess, R Robson and D J Birkett
      Molecular Pharmacology August 1987, 32 (1) 189-194;

  17. Sweatlock, J

    1. alpha-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression.
      J A Blank, A N Tucker, J Sweatlock, T A Gasiewicz and M I Luster
      Molecular Pharmacology July 1987, 32 (1) 169-172;

T

  1. Tabakoff, B

    1. Effect of ethanol on mouse cerebral cortical beta-adrenergic receptors.
      P Valverius, P L Hoffman and B Tabakoff
      Molecular Pharmacology August 1987, 32 (1) 217-222;

  2. Tanaka, T

    1. Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
      M Hagiwara, M Inagaki, M Watanabe, M Ito, K Onoda, T Tanaka and H Hidaka
      Molecular Pharmacology July 1987, 32 (1) 7-12;

  3. Tanfin, Z

    1. Heterologous regulations of cAMP responses in pregnant rat myometrium. Evolution from a stimulatory to an inhibitory prostaglandin E2 and prostacyclin effect.
      Z Tanfin and S Harbon
      Molecular Pharmacology August 1987, 32 (1) 249-257;

  4. Taylor, P

    1. The relationship between alpha 1-adrenergic receptor occupancy and response in BC3H-1 muscle cells.
      R D Brown, K D Berger and P Taylor
      Molecular Pharmacology July 1987, 32 (1) 43-52;

  5. Tephly, T R

    1. The role of formate and S-adenosylmethionine in the reversal of nitrous oxide inhibition of formate oxidation in the rat.
      A B Makar and T R Tephly
      Molecular Pharmacology August 1987, 32 (1) 309-314;

  6. Thomas, P E

    1. Co-induction of cytochrome P-450 isozymes in rat liver by 2,4,5,2',4',5'-hexachlorobiphenyl or 3-methoxy-4-aminoazobenzene.
      M Kelley, P Hantelle, S Safe, W Levin and P E Thomas
      Molecular Pharmacology August 1987, 32 (1) 206-211;

  7. Thurman, R G

    1. Effect of beta-naphthoflavone on mitochondrial supply of reducing equivalents for monooxygenation in periportal and pericentral regions of the liver lobule.
      S A Belinsky, F W Kari, F C Kauffman and R G Thurman
      Molecular Pharmacology August 1987, 32 (1) 315-320;

  8. Trager, W F

    1. Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implications.
      L M Bornheim, M C Underwood, P Caldera, A E Rettie, W F Trager, S A Wrighton and M A Correia
      Molecular Pharmacology August 1987, 32 (1) 299-308;

  9. Tucker, A N

    1. alpha-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression.
      J A Blank, A N Tucker, J Sweatlock, T A Gasiewicz and M I Luster
      Molecular Pharmacology July 1987, 32 (1) 169-172;

U

  1. Underwood, M C

    1. Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implications.
      L M Bornheim, M C Underwood, P Caldera, A E Rettie, W F Trager, S A Wrighton and M A Correia
      Molecular Pharmacology August 1987, 32 (1) 299-308;

V

  1. Valverius, P

    1. Effect of ethanol on mouse cerebral cortical beta-adrenergic receptors.
      P Valverius, P L Hoffman and B Tabakoff
      Molecular Pharmacology August 1987, 32 (1) 217-222;

  2. Varrichio, A

    1. Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be related.
      R G Shorr, M D Minnich, A Varrichio, M W Strohsacker, L Gotlib, L I Kruse, W E DeWolf and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 195-200;

  3. Vauquelin, G

    1. Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors.
      A Convents, J P De Backer, D Convents and G Vauquelin
      Molecular Pharmacology July 1987, 32 (1) 65-72;

W

  1. Waelbroeck, M

    1. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
      M Gillard, M Waelbroeck and J Christophe
      Molecular Pharmacology July 1987, 32 (1) 100-108;
    2. Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
      M Waelbroeck, M Gillard, P Robberecht and J Christophe
      Molecular Pharmacology July 1987, 32 (1) 91-99;

  2. Watanabe, M

    1. Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
      M Hagiwara, M Inagaki, M Watanabe, M Ito, K Onoda, T Tanaka and H Hidaka
      Molecular Pharmacology July 1987, 32 (1) 7-12;

  3. Woolkalis, M J

    1. Structural characteristics of the 35- and 36-kDa forms of the beta subunit common to GTP-binding regulatory proteins.
      M J Woolkalis and D R Manning
      Molecular Pharmacology July 1987, 32 (1) 1-6;

  4. Wrighton, S A

    1. Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implications.
      L M Bornheim, M C Underwood, P Caldera, A E Rettie, W F Trager, S A Wrighton and M A Correia
      Molecular Pharmacology August 1987, 32 (1) 299-308;

  5. Wu, H L

    1. SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
      S Mong, H L Wu, J Miller, R F Hall, J G Gleason and S T Crooke
      Molecular Pharmacology August 1987, 32 (1) 223-229;

Y

  1. Yang, J S

    1. gamma-Aminobutyric acid receptor binding in fresh mouse brain membranes at 22 degrees C: ligand-induced changes in affinity.
      J S Yang and R W Olsen
      Molecular Pharmacology August 1987, 32 (1) 266-277;

  2. Yang, S K

    1. Stereoselective formations of K-region and non-K-region epoxides in the metabolism of chrysene by rat liver microsomal cytochrome P-450 isozymes.
      S K Yang and Z P Bao
      Molecular Pharmacology July 1987, 32 (1) 73-80;
Back to top

In this issue

Advertisement